According to Iridex Corp., the study confirms MicroPulse TLT's sustained safety and efficacy in managing glaucoma, reducing ...

Omeros shares gained Thursday after the company shared positive results for a trial of its treatment of a stem-cell transplantation complication. The stock rose 52% to $11.15. It has nearly doubled ...